Company Information

Revenue, expenses and profitability over five years.

Income Statement

REMUS PHARMACEUTICALS LTD.

Financial Data

All amounts are in ₹ crore unless stated otherwise.

Showing Standalone data

Five-year standalone Income Statement for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	93.99	78.21	63.50	45.03	24.72
Other Operating Revenues	0.00	0.95	0.00	0.00	0.00
Total Operating Revenues	93.99	79.16	63.50	45.03	24.72

Other Income	6.84	2.91	3.69	1.58	0.72
Total Revenue	100.83	82.07	67.19	46.60	25.44

EXPENSES
Purchase Of Stock-In Trade	41.29	35.27	29.21	20.14	12.71
Changes In Inventories Of FG,WIP And Stock-In Trade	-0.63	-0.23	-1.38	1.30	-0.44
Employee Benefit Expenses	8.54	9.17	6.56	5.47	3.49
Finance Costs	0.58	0.38	0.32	0.23	0.09
Depreciation And Amortisation Expenses	2.75	1.87	0.90	0.48	0.15
Other Expenses	15.07	8.97	9.06	7.57	4.89
Total Expenses	67.60	55.43	44.67	35.19	20.89

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	33.23	26.64	22.52	11.41	4.55

Profit/Loss Before Tax	33.23	26.64	22.52	11.41	4.55

Tax Expenses-Continued Operations
Current Tax	8.52	6.67	6.45	3.00	1.19
Deferred Tax	0.00	0.07	-0.71	-0.09	-0.03
Tax For Earlier Years	0.00	0.00	-0.03	0.00	0.00
Total Tax Expenses	8.52	6.74	5.71	2.91	1.16
Profit/Loss After Tax And Before ExtraOrdinary Items	24.71	19.90	16.82	8.50	3.39

Profit/Loss From Continuing Operations	24.71	19.90	16.82	8.50	3.39

Profit/Loss For The Period	24.71	19.90	16.82	8.50	3.39

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	20.96	33.75	118.72	83.24	33.86
Diluted EPS (Rs.)	20.96	33.75	118.72	83.24	33.86

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	1.18	0.59	0.00	0.00
Equity Dividend Rate (%)	5.00	15.00	60.00	20.00	0.00

Five-year consolidated Income Statement for the selected company
Particulars	Mar 26	Mar 25	Mar 24
Months	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR
FaceValue	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	853.63	610.32	212.50
Other Operating Revenues	0.00	10.04	0.00
Total Operating Revenues	853.63	620.36	212.50

Other Income	6.70	4.98	5.40
Total Revenue	860.33	625.34	217.90

EXPENSES
Purchase Of Stock-In Trade	762.71	541.31	164.99
Changes In Inventories Of FG,WIP And Stock-In Trade	-20.50	-8.44	-0.67
Employee Benefit Expenses	12.82	13.11	7.42
Finance Costs	1.47	1.46	0.48
Depreciation And Amortisation Expenses	2.76	1.87	0.90
Other Expenses	41.91	28.69	12.94
Total Expenses	801.17	578.00	186.07

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	59.16	47.34	31.83

Profit/Loss Before Tax	59.16	47.34	31.83

Tax Expenses-Continued Operations
Current Tax	12.99	8.85	6.60
Deferred Tax	0.00	0.07	-0.71
Tax For Earlier Years	0.00	0.00	-0.03
Total Tax Expenses	12.99	8.92	5.85
Profit/Loss After Tax And Before ExtraOrdinary Items	46.17	38.42	25.98

Profit/Loss From Continuing Operations	46.17	38.42	25.98

Profit/Loss For The Period	46.17	38.42	25.98

Minority Interest	-9.18	-9.35	0.00
Consolidated Profit/Loss After MI And Associates	36.99	29.07	25.98

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	39.19	65.21	152.01
Diluted EPS (Rs.)	39.19	65.21	152.01

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	1.18	0.59

Source: Financial statements as reported by the company.